Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- SPRINGIndependent statistical analysis of Survival Prolongation by Rationale Innovative Genomics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03386929).
- SPRING-2Independent statistical analysis of A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPRINTIndependent statistical analysis of Tecemotide (L-BLP25) in Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01507103).
- SPRINTIndependent statistical analysis of The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03523702).
- SPRINT-2Independent statistical analysis of Safety and Efficacy of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 (Study P05216AM2) (COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SprixIndependent statistical analysis of An Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SPROUTIndependent statistical analysis of Mobile App for Prenatal Care to Reduce Visits and Improve Satisfaction Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPSIndependent statistical analysis of Stem Cell Transplantation for Stiff Person Syndrome (SPS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02282514).
- SPTIndependent statistical analysis of Brain Biomarkers of Response to Treatment for Apraxia of Speech: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02046941).
- SPT for Sensitization of Collagen Dressing: Complete Statistical AnalysisIndependent statistical analysis of SPT for Sensitization of Collagen Dressing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06271993).
- SPT2DIndependent statistical analysis of The Set-Point Study for Type 2 Diabetes: Evaluating the Use of an Insulin Only Bionic Pancreas System in Type 2 Diabetes: primary endpoint results, effect estimate with confidence…
- Sputum-derived Cellular Targets After Xolair (Omalizumab): Complete Statistical AnalysisIndependent statistical analysis of Sputum-derived Cellular Targets After Xolair (Omalizumab): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02658877).
- SPYDSIndependent statistical analysis of Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02524418).
- SQ53 Disinfectant Wipes for Prevention of CRBSI: Complete Statistical AnalysisIndependent statistical analysis of SQ53 Disinfectant Wipes for Prevention of CRBSI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04822467).
- SQUELCH-CIndependent statistical analysis of Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01821625).
- SR-WBV Training for Frail Elderly in the Skilling up Stage: Complete Statistical AnalysisIndependent statistical analysis of SR-WBV Training for Frail Elderly in the Skilling up Stage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01704976).
- SRSIndependent statistical analysis of Stereotactic Radiosurgery (SRS) Dose-Escalation Study for Brain Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02645487).
- SRSIndependent statistical analysis of Stereotactic Radiosurgery (SRS) for Spine Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00593320).
- SRSEIndependent statistical analysis of Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SRT5Independent statistical analysis of Predictors of Response in Chronic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04283253).
- SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma: Complete Statistical AnalysisIndependent statistical analysis of SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01362790).
- SSB 11-02Independent statistical analysis of Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1: primary endpoint results, effect estimate with confidence…
- SSETDIndependent statistical analysis of Supportive and Supportive-Expressive Treatment for Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02728557).
- SSVSIndependent statistical analysis of Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SSWIndependent statistical analysis of Sun Safe Workplaces: A Campaign on Sun Protection Policies for Outdoor Workers Phase I: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- St. Joe’s Invitation Effectiveness Study: Complete Statistical AnalysisIndependent statistical analysis of St. Joe's Invitation Effectiveness Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04658888).
- St. John’s Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients: Complete Statistical AnalysisIndependent statistical analysis of STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- STABIL-BIndependent statistical analysis of Sequential Therapy for the Treatment of Severe Bipolar Depression.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02974010).
- Stability of the Medial Pivot Total Knee Prosthesis: Complete Statistical AnalysisIndependent statistical analysis of Stability of the Medial Pivot Total Knee Prosthesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02577978).
- Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Staccato Loxapine in Agitated Patients With Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Staccato Loxapine in Agitated Patients With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00721955).
- Staccato Loxapine in Agitation (Proof of Concept): Complete Statistical AnalysisIndependent statistical analysis of Staccato Loxapine in Agitation (Proof of Concept): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00369577).
- Staccato Prochlorperazine in Migraine (Out Patient): Complete Statistical AnalysisIndependent statistical analysis of Staccato Prochlorperazine in Migraine (Out Patient): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00422812).
- STAGEIndependent statistical analysis of A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- STAGEIndependent statistical analysis of STorz Against Glidescope Effectiveness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01632683).
- Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab: Complete Statistical AnalysisIndependent statistical analysis of Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab: primary endpoint results, effect estimate with confidence…
- Stage I/II Nasal NK Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Stage I/II Nasal NK Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01321008).
- Staged DEEPIndependent statistical analysis of Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01661205).
- STAGED-PKD-EXTIndependent statistical analysis of Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Staging and Outcome Depending on Surgical Treatment in Adenocarcinomas of the Oesophagogastric Junction: Complete Statistical AnalysisIndependent statistical analysis of Staging and Outcome Depending on Surgical Treatment in Adenocarcinomas of the Oesophagogastric Junction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- STAMP+CBTIndependent statistical analysis of Psychological Intervention Using Smartphone Technology to Alleviate Malignant Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05774197).
- STAMPVAIndependent statistical analysis of Sharing and Talking About my Preferences: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03103828).
- STANIndependent statistical analysis of Fetal ST Segment and T Wave Analysis in Labor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01131260).
- STANCEIndependent statistical analysis of Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02850081).
- STANDIndependent statistical analysis of Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- STANDIndependent statistical analysis of Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- STANDIndependent statistical analysis of A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Stand if You Can: A Standing Intervention in Long Term Care: Complete Statistical AnalysisIndependent statistical analysis of Stand if You Can: A Standing Intervention in Long Term Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…